Notice Information
Notice Title
Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients
Notice Description
In-line with All Wales Medical genomic Service's (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.
Lot Information
Lot 1
NWSSP Procurement Services intends to award a contract on behalf of Cardiff and Vale University Health Board, AWMGS, for the supply of whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing from CeGAT. The contract is estimated to commence in June 2024, for a period of two years.
Procurement Information
All Wales Genomics Service (AWMGS) is commissioned by the NHS Wales Joint Commissioning Committee (JCC) (formally WHSSC) to provide genetic testing for Welsh patients which is equitable to the Clinical Indications stated in the NHSE Rare and Inherited Disease Test Directory. NHS E patients can currently access a range of Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) tests for rare and inherited diseases delivered from within the 7 Genomic Laboratory Hub service model. As a single service provider within Wales, there is necessarily a reliance on external services to enable delivery of the entire Test Directory. In-house service developments are ongoing to increase the number of genetic tests delivered from within AWMGS and there are significant repatriations planned but these will not go-live until 2025 - 27 (services will be introduced over a 18-24-month basis) following completion of the GLIMS and relocation projects. Due to a lack of testing capacity of NHS England laboratories to carry out the WGS based tests, reliance has been made on incumbent private provider CeGat. Given current organisational pressures to deliver an effective service, it has been noted that additional capacity be provided to supress demand. Equally, CeGAT have absorbed the sample courier responsibilities as part of the sample pathway, which has reduced the impact on AWMGS staffing. There have also been a number of MDT mechanisms established to ensure that reporting of patient results is consistent between AWMGS and CeGaT. This is critical to service delivery as it ensures equity for patients that are being referred to AWMGS and means that they are not at risk of receiving differing testing approaches depending on if testing was delivered in house or via an external laboratory. This level of bespoke service and customisation meeting the specification defined in the AWMGS standard operating procedures and consistent with UK best practice reporting guidelines is essential to delivering a robust and equitable, high-quality service. Given the bespoke attributes of the current contract, a direct award approach negates additional expenditure of the service and extended timelines.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-kuma6s-141500
- Publication Source
- Sell2Wales
- Latest Notice
- https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=141500
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- OJEU - F15 - Voluntary Ex Ante Transparency Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33910000 - Pathology dissection instruments and supplies
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £660,000 £500K-£1M
Notice Dates
- Publication Date
- 15 May 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 15 May 20241 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
- Contact Name
- Not specified
- Contact Email
- rhys.wathan@wales.nhs.uk
- Contact Phone
- +44 1443848585
Buyer Location
- Locality
- CARDIFF
- Postcode
- CF15 7QZ
- Post Town
- Cardiff
- Country
- Wales
-
- Major Region (ITL 1)
- TLL Wales
- Basic Region (ITL 2)
- TLL5 South East Wales
- Small Region (ITL 3)
- TLL51 Central Valleys and Bridgend
- Delivery Location
- TLL22 Cardiff and Vale of Glamorgan
-
- Local Authority
- Rhondda Cynon Taf
- Electoral Ward
- Taff's Well
- Westminster Constituency
- Cardiff North
Further Information
Notice Documents
-
https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAY478032
Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients - In-line with All Wales Medical genomic Service's (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-kuma6s-141500-2024-05-15T00:00:00Z",
"date": "2024-05-15T00:00:00Z",
"ocid": "ocds-kuma6s-141500",
"initiationType": "tender",
"parties": [
{
"id": "org-8",
"name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
"identifier": {
"legalName": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
},
"address": {
"streetAddress": "4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw",
"locality": "Cardiff",
"region": "UK",
"postalCode": "CF15 7QZ"
},
"contactPoint": {
"email": "rhys.wathan@wales.nhs.uk",
"telephone": "+44 1443848585"
},
"roles": [
"buyer"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
}
},
{
"id": "org-9",
"name": "CeGaT GmbH",
"identifier": {
"legalName": "CeGaT GmbH"
},
"address": {
"streetAddress": "Paul-Ehrlich-Strasse 23",
"locality": "Tubingen",
"region": "DE1",
"postalCode": "D72076"
},
"contactPoint": {
"telephone": "+44 7500081932"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "org-3",
"name": "High Court",
"identifier": {
"legalName": "High Court"
},
"address": {
"streetAddress": "Royal Courts of Justice, The Strand",
"locality": "London",
"postalCode": "WC2A 2LL"
},
"contactPoint": {
"telephone": "+44 2079477501"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
"id": "org-8"
},
"tender": {
"id": "ocds-kuma6s-141500-tender-141500",
"title": "Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients",
"description": "In-line with All Wales Medical genomic Service's (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.",
"status": "complete",
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKL22"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "All Wales Genomics Service (AWMGS) is commissioned by the NHS Wales Joint Commissioning Committee (JCC) (formally WHSSC) to provide genetic testing for Welsh patients which is equitable to the Clinical Indications stated in the NHSE Rare and Inherited Disease Test Directory. NHS E patients can currently access a range of Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) tests for rare and inherited diseases delivered from within the 7 Genomic Laboratory Hub service model. As a single service provider within Wales, there is necessarily a reliance on external services to enable delivery of the entire Test Directory. In-house service developments are ongoing to increase the number of genetic tests delivered from within AWMGS and there are significant repatriations planned but these will not go-live until 2025 - 27 (services will be introduced over a 18-24-month basis) following completion of the GLIMS and relocation projects. Due to a lack of testing capacity of NHS England laboratories to carry out the WGS based tests, reliance has been made on incumbent private provider CeGat. Given current organisational pressures to deliver an effective service, it has been noted that additional capacity be provided to supress demand. Equally, CeGAT have absorbed the sample courier responsibilities as part of the sample pathway, which has reduced the impact on AWMGS staffing. There have also been a number of MDT mechanisms established to ensure that reporting of patient results is consistent between AWMGS and CeGaT. This is critical to service delivery as it ensures equity for patients that are being referred to AWMGS and means that they are not at risk of receiving differing testing approaches depending on if testing was delivered in house or via an external laboratory. This level of bespoke service and customisation meeting the specification defined in the AWMGS standard operating procedures and consistent with UK best practice reporting guidelines is essential to delivering a robust and equitable, high-quality service. Given the bespoke attributes of the current contract, a direct award approach negates additional expenditure of the service and extended timelines.",
"mainProcurementCategory": "goods",
"documents": [
{
"id": "MAY478032",
"documentType": "awardNotice",
"title": "Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients",
"description": "In-line with All Wales Medical genomic Service's (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.",
"url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAY478032",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "NWSSP Procurement Services intends to award a contract on behalf of Cardiff and Vale University Health Board, AWMGS, for the supply of whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing from CeGAT. The contract is estimated to commence in June 2024, for a period of two years.",
"status": "complete",
"hasOptions": false
}
],
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"classification": {
"id": "33910000",
"scheme": "CPV"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
}
},
"awards": [
{
"id": "ocds-kuma6s-141500-award-141500-4",
"suppliers": [
{
"id": "org-9",
"name": "CeGaT GmbH"
}
],
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "ocds-kuma6s-141500-award-141500-4",
"awardID": "ocds-kuma6s-141500-award-141500-4",
"status": "active",
"value": {
"amount": 660000,
"currency": "GBP"
},
"dateSigned": "2024-05-15T00:00:00Z"
}
],
"language": "EN",
"description": "NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=141500. (WA Ref:141500)",
"links": [
{
"rel": "canonical",
"href": "https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-141500"
}
],
"noticetype": "OJEU - F15 - Voluntary Ex Ante Transparency Notice"
}